1. Home
  2. CSPI vs PEPG Comparison

CSPI vs PEPG Comparison

Compare CSPI & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$9.81

Market Cap

98.5M

Sector

Technology

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$1.50

Market Cap

121.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
PEPG
Founded
1968
2018
Country
United States
United States
Employees
123
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
121.7M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
CSPI
PEPG
Price
$9.81
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.17
AVG Volume (30 Days)
9.9K
883.1K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
1.15%
N/A
EPS Growth
75.00
25.61
EPS
0.04
N/A
Revenue
$58,730,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$233.13
N/A
Revenue Growth
6.36
N/A
52 Week Low
$7.55
$1.01
52 Week High
$15.49
$7.80

Technical Indicators

Market Signals
Indicator
CSPI
PEPG
Relative Strength Index (RSI) 57.65 35.85
Support Level $9.72 $1.32
Resistance Level $10.59 $5.37
Average True Range (ATR) 0.58 0.15
MACD 0.00 0.05
Stochastic Oscillator 65.32 24.11

Price Performance

Historical Comparison
CSPI
PEPG

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: